Vor Biopharma Inc [NASDAQ: VOR] price plunged by -3.18 percent to reach at -$0.05.
A sum of 5397854 shares traded at recent session while its average daily volume was at 18.69M shares. Vor Biopharma Inc shares reached a high of $1.64 and dropped to a low of $1.48 until finishing in the latest session at $1.52.
The one-year VOR stock forecast points to a potential downside of -28.81. The average equity rating for VOR stock is currently 2.50, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Vor Biopharma Inc [VOR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VOR shares is $1.18 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VOR stock is a recommendation set at 2.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Vor Biopharma Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 30, 2025. While these analysts kept the previous recommendation, Wedbush raised their target price to Outperform. The new note on the price target was released on July 26, 2022, representing the official price target for Vor Biopharma Inc stock. Previously, the target price had yet another raise to $6, while Goldman analysts kept a Neutral rating on VOR stock.
VOR Stock Performance Analysis:
Vor Biopharma Inc [VOR] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -15.56. With this latest performance, VOR shares dropped by -25.49% in over the last four-week period, additionally plugging by 83.91% over the last 6 months – not to mention a rise of 36.94% in the past year of trading.
Vor Biopharma Inc (VOR) Capital Structure & Debt Analysis
Vor Biopharma Inc (VOR) Efficiency & Liquidity Metrics
Vor Biopharma Inc (VOR) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Vor Biopharma Inc. (VOR) effectively leverages its workforce, generating an average of -$10468113.21 per employee. The company’s liquidity position is robust, with a Current Ratio of 3.49% and a Quick Ratio of 3.49%, indicating strong ability to cover short-term liabilities.
VOR Stock EPS
With the latest financial reports released by the company, Vor Biopharma Inc posted -0.4/share EPS, while the average EPS was predicted by analysts to be reported at -0.4/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VOR. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Vor Biopharma Inc go to 17.49%.
Vor Biopharma Inc [VOR] Institutonal Ownership Details
There are presently around $43.63%, or 70.71%% of VOR stock, in the hands of institutional investors. The top three institutional holders of VOR stocks are: RA CAPITAL MANAGEMENT, L.P. with ownership of 22.75 million shares, which is approximately 33.439%. FMR LLC, holding 7.08 million shares of the stock with an approximate value of $$7.08 million in VOR stocks shares; and FMR LLC, currently with $$6.46 million in VOR stock with ownership which is approximately 9.4917%.
